(Q44790817)

6 December 2017

title

Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany (English)

1 reference

6 December 2017

0 references

1 reference

Nicole Wueppenhorst

1

1 reference

6 December 2017

Hans-Peter Stueger

series ordinal

2

1 reference

6 December 2017

Manfred Kist

series ordinal

3

1 reference

6 December 2017

Erik Glocker

series ordinal

4

1 reference

6 December 2017

language of work or name

English

0 references

publication date

3 February 2009

1 reference

Journal of Antimicrobial Chemotherapy

6 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 December 2017

volume

63

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

648-653

1 reference

Helicobacter pyloriInfection

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Helicobacter pylori "rescue" therapy after failure of two eradication treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Helicobacter pylori detection and antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Quinolone resistance in Helicobacter pylori isolates in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Levofloxacin-resistant Helicobacter pylori in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Real-time PCR screening for 16S rRNA mutations associated with resistance to tetracycline in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Single and double mutations in gyrA but not in gyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Helicobacter pylori and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

CYP2C19 polymorphism and proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKP003

21 January 2018

Identifiers

DOI

10.1093/JAC/DKP003

1 reference

6 December 2017

1 reference